There are 3397 resources available
LBA50 - Three-year survival with tebentafusp in previously untreated metastatic uveal melanoma in a phase III trial
Presenter: Sophie Piperno-Neumann
Session: Mini oral session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 2032MO, 1843MO, 2033MO
Presenter: Christina Ruhlmann
Session: Mini oral session - Supportive and palliative care
Resources:
Slides
Webcast
Invited Discussant 1687O, 1688O and 1689O
Presenter: Alessio Cortellini
Session: Proffered paper session: Policy and preventive strategies
Resources:
Slides
Webcast
Triple-negative breast cancer
Presenter: Andreas Schneeweiss
Session: Optimal treatment sequence in metastatic breast cancer (mBC) in 2023
Resources:
Slides
Webcast
Invited Discussant 1988MO, 1989MO and 1990MO
Presenter: Andrea Ardizzoni
Session: Mini oral session 1 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Invited Discussant LBA87, LBA88 and 1881O
Presenter: Lisa Pickering
Session: Proffered Paper session 2 - Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
Managing progression after TKIs in oncogenic fusion-driven lung cancer
Presenter: Jessica Lin
Session: Managing disease progression in oncogene-driven lung cancer
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Integrating immunotherapy into the standard of care for cervical cancer
Resources:
Webcast
Q&A and Discussion
Presenter: All Speakers
Session: Is neoadjuvant immunotherapy a therapeutic platform for all tumour types?
Resources:
Slides
Webcast
Toxicities of TILs, CAR-Ts and bispecific antibodies
Presenter: Anastasios Stathis
Session: Management of novel treatments’ toxicities
Resources:
Slides
Webcast